Cardiol Therapeutics Inc. (CRDL)
NASDAQ: CRDL · Real-Time Price · USD
1.900
+0.030 (1.60%)
Nov 4, 2024, 4:00 PM EST - Market closed

Cardiol Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2017
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2017
Market Capitalization
15354321127291
Upgrade
Market Cap Growth
140.96%67.34%-71.06%56.56%-21.55%23.29%
Upgrade
Enterprise Value
13624-16905984
Upgrade
Last Close Price
1.900.840.511.852.183.54
Upgrade
PE Ratio
--2.55-1.39-3.20-4.02-8.66
Upgrade
PS Ratio
---1803.25--
Upgrade
PB Ratio
12.262.540.841.866.888.08
Upgrade
P/FCF Ratio
-8.72-2.84-1.61-6.03-9.96-10.04
Upgrade
P/OCF Ratio
-8.73-2.85-1.61-6.03-10.01-10.41
Upgrade
EV/Sales Ratio
---1441.08--
Upgrade
EV/EBITDA Ratio
-5.05-1.060.52-2.95-3.66-9.23
Upgrade
EV/EBIT Ratio
-5.03-1.050.52-2.94-3.62-9.13
Upgrade
EV/FCF Ratio
-7.41-1.240.79-4.82-8.17-9.20
Upgrade
Debt / Equity Ratio
0.010.010.000.000.010.01
Upgrade
Debt / FCF Ratio
-0.01-0.010.000.00-0.02-0.02
Upgrade
Asset Turnover
---0.00--
Upgrade
Quick Ratio
2.244.246.117.295.6611.42
Upgrade
Current Ratio
2.394.366.277.535.9420.81
Upgrade
Return on Equity (ROE)
-108.43%-69.93%-48.16%-70.69%-147.74%-74.08%
Upgrade
Return on Assets (ROA)
-54.15%-37.71%-34.47%-46.58%-82.38%-36.99%
Upgrade
Return on Capital (ROIC)
-73.24%-46.14%-40.17%-53.83%-91.42%-39.75%
Upgrade
Earnings Yield
-14.01%-39.19%-70.37%-22.28%-22.60%-11.55%
Upgrade
FCF Yield
-10.15%-35.17%-62.10%-16.58%-10.04%-9.96%
Upgrade
Buyback Yield / Dilution
-4.44%-3.13%-44.61%-44.77%-15.63%-67.97%
Upgrade
Total Shareholder Return
-4.44%-3.13%-44.61%-44.77%-15.63%-67.97%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.